MONTERREY, Mexico, Sept. 14, 2026 (GLOBE NEWSWIRE) — Fomento Económico Mexicano, S.A.B. de C.V. (“FEMSA” or the “Company”) (NYSE: FMX; BMV: FEMSAUBD, FEMSAUB) today announced that, as part of its ongoing efforts and consistent with its capital allocation framework and commitment to enhance capital returns to shareholders, it has entered into a new derivative instrument known as an accelerated share repurchase (“ASR”) agreement with a financial institution in the United States of America to repurchase Company’s shares through the acquisition of American Depositary Shares (“ADS”). Under the terms of the ASR agreement, FEMSA has agreed to repurchase from such financial institution an aggregate amount of up to USD $280 million of its ADS1, subject to market conditions and delivered at maturity.

The final number of ADSs repurchased and delivered under the ASR agreement will be based on the daily volume-weighted average ADS price during the agreement term, less a discount, and subject to the agreement’s terms and conditions. Final settlement is expected to occur before year-end 2026.

About FEMSA
FEMSA is a company that creates economic and social value through companies and institutions and strives to be the best employer and neighbor to the communities in which it operates. It participates in two core sectors, retail and beverages. In retail, FEMSA is present through four divisions: i) OXXO Mexico, operating the largest small-format store chain in Mexico; ii) Americas & Mobility, which includes its OXXO convenience store operations across Latin America and the United States, as well as its gas station business in Mexico and the United States; iii) Europe, operating convenience and foodvenience formats in five European countries; and iv) FEMSA Health, which includes drugstores and related activities in four Latin American countries. In Mexico, OXXO’s operations are enhanced by, and comprise a customer-focused ecosystem with Spin, a digital platform that leverages the OXXO store network to provide Mexican consumers with access to digital financial services, including Spin by OXXO and Spin Premia, among other initiatives. In the beverage sector, FEMSA participates through Coca-Cola FEMSA, the largest franchise bottler of Coca-Cola products in the world by volume. Across its business units, FEMSA has more than 369,000 employees in 18 countries. FEMSA is a member of the Dow Jones Best-in-Class World Index & Dow Jones Best-in-Class MILA Pacific Alliance Index, both from S&P Global; FTSE4Good Emerging Index; MSCI EM Latin America ESG Leaders Index; S&P/BMV Total México ESG, among other indexes.

__________________________________________________
1
ADS underlying units consist of 10 of FEMSA’s BD Units, each representing one Series B Share, two Series D-B Shares and two Series D-L Shares, without par value.

CONTACT: Investor Contact
(52) 818-328-6000
investor@femsa.com
femsa.gcs-web.com

Media Contact
(52) 555-249-6843
comunicacion@femsa.com
femsa.com

Artea Bankas AB, company code 112025254, address of the head office Tilžės str. 149, Šiauliai, Lithuania.

Artea bankas AB has received the notification of the persons, closely associated with the manager, in securities issued by the bank (attached). 

Additional information: 
Arnas Šukys 
Head of Investor Relations
arnas.sukys@artea.lt, +370 610 44447

Attachment

Highlights 3nm Production, 2nm Design, 3DIC Capabilities and Multi-Die Advanced Packaging

SAN JOSE, Calif., Sept. 14, 2026 (GLOBE NEWSWIRE) — Alchip Technologies, the high-performance ASIC leader, will showcase its leading-edge process technology and advanced packaging achievements in Booth 1705 at AI Infra Summit 2026.

The event runs from September 15 through September 17 at the Santa Clara Convention Center in Santa Clara, California.

At the exhibit, Alchip will discuss its 3nm designs in production and 2nm designs currently in development. The company will also showcase its complete 2nm design platform, 3nm I/O chiplet support, and functional optical interconnect capabilities. Today, 90% of the company’s designs use process technologies below 7nm.

Alchip will also focus on its advanced packaging capabilities, highlighting its 3DIC ecosystem readiness and experience working with multiple TSMC CoWoS® technologies. These capabilities include TSMC 2nm CoWoS® designs, TSMC CoWoS®-S and TSMC CoWoS®-R designs in production, TSMC CoWoS®-L and TSMC SoIC®-X designs in development. The company will highlight its proven 3DIC capabilities, co-packaged optics technology and high-performance die-to-die IP.

Alchip has completed more than 650 successful tape-outs since its founding in 2003 and currently completes 10 to 20 new tape-outs annually. Its track record covers more than 60 FinFET designs and more than 20 CoWoS designs, with a focus on AI and high-performance computing, networking and automotive applications.

About Alchip

Alchip Technologies Ltd., founded in 2003 and headquartered in Taipei, Taiwan, is a leading global High-Performance Computing and AI infrastructure ASIC provider of IC and packaging design, and production services for companies developing complex and high-volume ASICs and SoCs.  Alchip provides faster time-to-market and cost-effective solutions for SoC design at mainstream and advanced process technology. Alchip has built its reputation as a high-performance ASIC leader through its advanced 2.5D/3D CoWoS packaging, chiplet design, and manufacturing management. Customers include global leaders in artificial intelligence, high-performance computing, supercomputing, mobile communications, entertainment device, networking equipment, and other electronic product categories. Alchip is listed on the Taiwan Stock Exchange (TWSE: 3661).

Note: CoWoS®, CoWoS®-S and CoWoS®-R, CoWoS®-L, SoIC®, and related advanced packaging terminology are trademarks or registered trademarks of Taiwan Semiconductor Manufacturing Company Limited (TSMC). They are used here solely to describe TSMC technologies incorporated within Alchip’s design and development activities.

For more information, please visit our website: http://www.alchip.com

CONTACT: Charles Byers
Alchip Technologies
+ (408)-310-9244
chuck_byers@alchip.com

ANDOVER, Mass., Sept. 14, 2026 (GLOBE NEWSWIRE) — MKS Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today released its 2026 Environmental, Social, Governance (“ESG”) Report, outlining how MKS continues to integrate sustainability into its strategy, operations, and decision-making to support long-term value creation.

“At MKS, operational excellence, risk management, and responsible growth, together with an unwavering commitment to innovation, integrity, and trust, are foundational to our sustainability efforts,” said John T.C. Lee, President and CEO. “This report details MKS’ continued progress in improving efficiency, reducing resource use, and supporting safer, more reliable operations, while making targeted investments that strengthen our global footprint and bring our expertise and resources closer to our customers.”

The 2026 ESG Report also highlights several of our key ESG achievements since the beginning of 2025, including:

  • Science Based Targets initiative (SBTi) approval of MKS’ near-term Scope 1, 2, and 3 greenhouse gas (GHG) emissions reduction targets.
  • Generation of approximately 1,500 MWh of electricity from a new rooftop solar installation at MKS’ Guangzhou, China equipment factory, avoiding nearly 900 tCO2e emissions annually.
  • Achievement of a record 91% participation rate in MKS’ fifth annual Global Employee Engagement Survey.
  • Continued external ESG recognition, including a low ESG risk rating from Sustainalytics and recognition as one of the Best Companies to Work For by U.S. News & World Report, one of America’s Best Midsized Companies by Time and Statista, Inc. and one of America’s Most Responsible Companies by Newsweek and Statista, Inc.

The report is available to view here and includes relevant disclosures related to The Sustainability Accounting Standards Board (SASB) and The Task Force on Climate-related Financial Disclosures (TCFD) standards.

About MKS Inc.
MKS Inc. (NASDAQ: MKSI) enables technologies that transform our world. We deliver foundational technology solutions to leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications. We apply our broad science and engineering capabilities to create instruments, subsystems, systems, process control solutions and specialty chemicals technology that improve process performance, optimize productivity and enable unique innovations for many of the world’s leading technology and industrial companies. Our solutions are critical to addressing the challenges of miniaturization and complexity in advanced device manufacturing by enabling increased power, speed, feature enhancement, and optimized connectivity. Our solutions are also critical to addressing ever-increasing performance requirements across a wide array of specialty industrial applications. Additional information can be found at www.mks.com.

Safe Harbor for Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 regarding MKS’ environmental goals. Any statements that are not statements of historical fact should be considered to be forward-looking statements. Actual events or results may differ materially from those in the forward-looking statements set forth herein as a result of various important factors, including the factors described in MKS’ Annual Report on Form 10-K for the year ended December 31, 2025, and any subsequent Quarterly Reports on Form 10-Q, as filed with the U.S. Securities and Exchange Commission. MKS is under no obligation to, and expressly disclaims any obligation to, update or alter these forward-looking statements, whether as a result of new information, future events or otherwise after the date of this press release.

Contacts:

Bill Casey
Vice President, Marketing
Telephone: +1 (630) 995-6384
Email: press@mksinst.com

Kerry Kelly, Partner
Kekst CNC
Email: kerry.kelly@kekstcnc.com

Independent research teams at MD Anderson Cancer Center, the University of Oulu, and the Josep Carreras Leukaemia Research Institute report that optical genome mapping (OGM) uncovers clinically significant genomic alterations missed by conventional cytogenetics, with direct implications for risk stratification across MDS, AML, and therapy-related myeloid neoplasms

SAN DIEGO, Sept. 14, 2026 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO) today highlighted three new independently authored, peer-reviewed publications demonstrating the clinical utility of OGM in high-risk hematologic malignancies — myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and therapy-related myeloid neoplasms (t-MN). The studies, published in Modern Pathology, the International Journal of Cancer, and npj Precision Oncology, reinforce a growing body of evidence that OGM can detect prognostically important structural genomic alterations that elude standard karyotyping, FISH, and targeted sequencing panels.

MD Anderson Cancer Center: Chromoanagenesis by OGM defines an ultra-high-risk MDS subset.

Researchers at The University of Texas MD Anderson Cancer Center, led by Guilin Tang, PhD, used OGM to study 332 samples from subjects with MDS, identifying chromoanagenesis (CAG), a catastrophic single-event genomic restructuring process, in 15.9% of cases overall and 17.6% of newly diagnosed subjects. The study, published in Modern Pathology (Wei et al., 2026), found that:

  • CAG-positive by OGM subjects had a median overall survival of just 9.9 months, significantly shorter than non-CAG subjects where median survival was not reached.
  • CAG by OGM showed the potential to confer prognostic information beyond existing risk-stratification systems, potentially enabling the identification of patients for early allogeneic transplantation or TP53-targeted clinical trials.


University of Oulu
: Cryptic structural variants uncovered in “normal karyotype” AML.

A separate study from the University of Oulu and collaborators, led by Tuomo Mantere, PhD, used OGM to analyze 48 samples of cytogenetically normal AML (CN-AML) — a subgroup that appears unremarkable on standard karyotyping but is clinically heterogeneous. Published in the International Journal of Cancer (Turtinen et al., 2026), the study found that:

  • OGM detected clinically relevant structural variants or copy-neutral loss-of-heterozygosity in 46% of cases classified as “normal” by conventional karyotyping.
  • Recurrent alterations included KMT2A partial tandem duplications (10% of cases), RUNX1 disruptions, NF1 deletions, and a novel putative FOXP1:EYA2 fusion not previously reported in the literature.
  • Subjects with OGM-detected abnormalities had significantly worse overall survival than those without (p = 0.005).

Josep Carreras Leukaemia Research Institute: OGM refines risk in therapy-related neoplasms and younger MDS.

A multicenter Spanish study led by Mar Mallo, PhD, and Francesc Solé, PhD, at the Josep Carreras Leukaemia Research Institute in collaboration with a Spanish hospital network applied OGM to two clinically distinct: 48 subjects with therapy-related myeloid neoplasms (t-MN) and 65 subjects with younger-onset MDS (yMDS, age ≤60). Published in npj Precision Oncology (Mestre et al., 2026), the study found that:

  • OGM was interpretable in 100% of samples, including all 8 cases where conventional banding analysis (CBA) failed due to lack of dividing cells, and identified 134 additional genomic alterations.
  • OGM refined cytogenetic classification in 52.0% of karyotypically abnormal cases and detected clinically relevant structural alterations in 9.8% of cases with a normal karyotype, including reclassification of subjects into the therapeutically relevant MDS with isolated 5q- category.
  • OGM-defined genomic complexity was independently associated with overall survival; chromoanagenesis emerged as the strongest independent predictor of inferior survival in multivariable analysis (HR 9.26), exceeding even TP53 mutation status.
  • Integrating OGM findings into IPSS-R and IPSS-M scoring shifted 16.7% of t-MN and up to 12.8% of yMDS subjects into higher-risk prognostic categories, which could have implications for treatment planning, including identification of biallelic TP53 inactivation.

Key highlights across all three studies:

  • Three independent academic centers, spanning the U.S., Finland, and Spain, each show the potential for OGM to identify clinically actionable genomic complexity that conventional cytogenetic workups miss.
  • All three studies link OGM findings directly to overall and/or disease-specific survival.
  • Findings support a potential role for OGM in refining prognostication beyond IPSS-R/IPSS-M and ELN2022 classification systems, including in patients who otherwise appear lower-risk by standard testing, and in cases where conventional karyotyping fails outright due to lack of dividing cells.
  • Across all three cohorts, chromoanagenesis and TP53 disruption consistently emerge as markers of a biologically distinct, ultra-high-risk disease subset best captured by genome-wide structural variant detection.

“These three independent studies, spanning MDS, AML, and therapy-related myeloid neoplasms, all point to the same conclusion: a meaningful fraction of high-risk genomic complexity in myeloid malignancies is simply invisible to conventional karyotyping,” said Al Luderer, PhD, chairman and interim chief executive officer of Bionano. “As OGM adoption continues to expand, we expect to see more of this kind of evidence connecting structural variant detection directly to potential patient outcomes and treatment decisions.”

Turtinen et al.: https://doi.org/10.1002/ijc.70548
Wei et al.: https://doi.org/10.1016/j.modpat.2026.101031
Mestre et al.: https://doi.org/10.1038/s41698-026-01671-z

About Bionano Genomics
Bionano is a provider of genome analysis solutions that enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through optical genome mapping (OGM) solutions, diagnostic services, and software. Bionano offers OGM solutions for applications across basic, translational, and clinical research, as well as an industry-leading, platform-agnostic genome analysis software solution and nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. Through its Bionano Laboratories business, the Company also offers OGM-based diagnostic testing services.

For more information, visit www.bionano.com or www.bionanolaboratories.com.
Bionano’s products are for research use only and not for use in diagnostic procedures.

Forward-Looking Statements of Bionano Genomics
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations or financial condition, business strategy and plans, and objectives of management for future operations, are forward-looking statements. Words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) convey uncertainty of future events or outcomes and are intended to identify forward-looking statements. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things: our expectations regarding market adoption of our products; our commercial prospects and future financial and operating results; and the utility of OGM for the applications referenced in this press release. Each of these forward-looking statements involves risks and uncertainties. Accordingly, investors and prospective investors are cautioned not to place undue reliance on these forward-looking statements as they involve inherent risk and uncertainty (both general and specific) and should note that they are provided as a general guide only and should not be relied on as an indication or guarantee of future performance. There are a number of important factors that could cause the actual results to differ materially from those expressed in any forward-looking statement made by us. These factors include, but are not limited to: our ability to improve our margins, extend our cash runway and reach a potential pathway to profitability; our ability to continue as a going concern as disclosed in our filings with the SEC, which requires us to manage costs and obtain significant additional financing to fund our strategic plans and commercialization efforts; our ability to execute on our strategy and achieve our objectives; the impact and utility of our cost savings initiative and our recent financing; our ability to continue to drive OGM (as defined above) adoption by potential customers for routine use in genomic analysis; the impact, or lack thereof, of Category I CPT codes to accelerate or increase the adoption of OGM; continued research, presentations and publications involving OGM and its utility compared to traditional cytogenetics and our technologies; the impact of our Stratys™ system and VIA™ software to increase throughput and simplify analysis of OGM data; our ability to drive adoption of OGM and our technology solutions; our ability to further deploy new products and applications for our technology platforms; our expectations and beliefs regarding future growth of the business and the markets in which we operate; our ability to consummate any strategic alternatives including the risk that if we fail to obtain additional financing we may seek relief under applicable insolvency laws; the size and growth potential of the markets for our products, and our ability to serve those markets; the rate and degree of market acceptance of our products; our ability to manage the growth of our business and integrate acquired businesses; the fact that we are limited to “research use only” with respect to many of the materials and components used in our consumable products including our assays; our ability to expand our commercial organization to address effectively existing and new markets that we intend to target; the impact from future regulatory, judicial, and legislative changes or developments in the U.S. and foreign countries; our ability to compete effectively in a competitive industry; the introduction of competitive technologies or improvements in existing technologies and the success of any such technologies; the performance of our third-party contract sales organizations, suppliers and manufacturers; our ability to attract and retain key scientific or management personnel; the accuracy of our estimates regarding expenses, future revenues, reimbursement rates, capital requirements and needs for additional financing; the impact of adverse geopolitical and macroeconomic developments, such as recent and future bank failures, ongoing international conflicts, and related sanctions, regional or global pandemics, inflation, tariffs, increased cost of goods, supply chain issues, and global financial market conditions; on our business and operations, as well as the business or operations of our suppliers, customers, manufacturers, research partners and other third parties with whom we conduct business and our expectations with respect to the duration of such impacts and the resulting effects on our business; our ability to realize the anticipated benefits and synergies of our prior and any future acquisitions or other strategic transactions; our ability to attract collaborators and strategic partnerships; and the risks and uncertainties associated with our business and financial condition in general, including the risks and uncertainties described in our filings with the Securities and Exchange Commission (“SEC”), including, without limitation, our Annual Report on Form 10-K for the year ended December 31, 2025, any subsequently filed Quarterly Reports on Form 10-Q and in other filings subsequently made by us with the SEC. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management’s assumptions and estimates as of such date. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise, except as may be required by law.

CONTACT

Investor Relations:
Webb Campbell
Gilmartin Group
+1 (415) 520-5817

LAVAL, Québec, Sept. 14, 2026 (GLOBE NEWSWIRE) — Savaria Corporation (“Savaria”) (TSX: SIS) one of the global leaders in the accessibility industry, announces today that its Board of Directors has approved an increase to the Corporation’s monthly dividend, raising it to 4.916 cents (0.04916 $) per common share. On an annual basis, this represents an increase of three cents ($0.03) or 5.36%, raising the dividend to 59 cents ($0.59) per common share. This increase will apply to the dividends payable monthly starting on October 9, 2026, to shareholders of record of the Corporation at the close of business on September 30, 2026. This is an eligible dividend within the meaning of the Income Tax Act (Canada).

A Word from the Executive Chairman

“As a result of our financial performance in 2025 and for the first six months of 2026, I am pleased to announce an increase in our dividend. This dividend increase reflects our confidence in continuing to deliver strong profitability in the coming years, while maintaining ample balance sheet flexibility by paying down debt and having the ability to invest in growth opportunities as they arise. So far in 2026 we have invested or have committed to invest approximately $40M by year end across acquisitions, including Vipal S.p.A. in Italy and Baxter in Texas, as well as the expansion of our manufacturing plant in Greenville, South Carolina.”, said Marcel Bourassa, Executive Chairman.

About Savaria Corporation

Savaria Corporation (corp.savaria.com) is one of the global leaders in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as elevators for home and commercial use, stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and dumbwaiters. In addition, Savaria manufactures and markets a comprehensive selection of pressure management products, medical beds, as well as an extensive line of medical equipment and solutions for the safe movement of patients, such as transfer, lifting and repositioning aids. The Corporation operates a sales network of dealers worldwide and direct sales offices in North America, Europe (UK, Netherlands, Switzerland, Italy, Germany, Poland and Czech Republic) and Australia. Savaria employs approximately 2,550 people globally and its plants are located across Canada, the United States, Mexico, Europe and China.

For further information:

Sébastien Bourassa
President and CEO
1. 800.661.5112 
sb@savaria.com
Stephen Reitknecht, CPA, CA
Chief Financial Officer
1.800.661.5112, ext. 3370
sreitknecht@savaria.com
 

Facebook : https://www.facebook.com/savariabettermobility
Instagram :https://www.instagram.com/savariacorp/
LinkedIn: https://ca.linkedin.com/company/savaria

WEST PALM BEACH, Fla., Sept. 14, 2026 (GLOBE NEWSWIRE) — Chatham Lodging Trust (NYSE: CLDT), a lodging real estate investment trust (REIT) that invests in upscale, extended-stay hotels and premium-branded, select-service hotels, today announced the appointment of Liam Brown to the company’s board of trustees, effective immediately. Brown will serve as an independent director.

Brown formerly was group president, United States and Canada of Marriott International, Inc., (“Marriott”) from January 2021 until his retirement in June 2026. In that role, he was responsible for the financial management and leadership of Marriott’s lodging operations in North and South America, comprising more than 6,000 hotels and a workforce of approximately 160,000 associates. Prior to this role, Brown served as the president and managing director of Europe of Marriott from 2018 to 2019, followed by group president of Europe, Middle East & Africa of Marriott in 2020. He joined Marriott in 1989 and served as president for franchising, owner services and managed by Marriott select brands, North America, from 2012 to 2018. Brown held other key positions with Marriott, including chief operations officer for the Americas for select service & extended stay lodging and owner & franchise services, as well as senior vice president and executive vice president of development for Marriott’s select service & extended stay lodging products.

Jeffrey H. Fisher, Chatham’s chairman of the board and chief executive officer, emphasized, “We have worked with Liam over the past 30 years and are excited to bring his extensive lodging expertise to our board. His resume speaks for itself, and his addition to the board brings substantial insights from both an operations and franchisor/franchisee relationship perspective that will be very helpful as we enhance shareholder value through continued focus on maximizing operating results and critical analysis of capital allocation decisions.”

Brown currently serves on the board of EPR Properties (NYSE: EPR), a publicly traded diversified experiential net lease REIT, where he is a member of the Compensation & Human Capital Committee (chair) and the Nominating/Company Governance Committee. He also serves on the Executive Committee of the American Hotel and Lodging Association. He holds a Hotel Diploma and Business Degree from the Dublin Institute of Technology, Trinity College and earned his Master of Business Administration from the Robert H. Smith School of Management at the University of Maryland.

About Chatham Lodging Trust

Chatham Lodging Trust is a self-advised, publicly-traded real estate investment trust focused primarily on investing in upscale, extended-stay hotels and premium-branded, select-service hotels. Additional information about Chatham may be found at chathamlodgingtrust.com.

Included in this press release are certain “non-GAAP financial measures,” within the meaning of Securities and Exchange Commission (SEC) rules and regulations, that are different from measures calculated and presented in accordance with GAAP (generally accepted accounting principles). The company considers the following non-GAAP financial measures useful to investors as key supplemental measures of its operating performance: (1) FFO, (2) Adjusted FFO, (3) EBITDA, and (4) Adjusted EBITDA. These non-GAAP financial measures could be considered along with, but not as alternatives to, net income or loss, cash flows from operations or any other measures of the company’s operating performance prescribed by GAAP.

Contact:  
Dennis Craven (Company) Chris Daly (Media)
Chief Operating Officer DG Public Relations
(561) 227-1386 (703) 864-5553

New suite of professionally constructed model portfolios brings asset selection, sizing, diversification, and rebalancing into a single framework for financial advisors

STAMFORD, Conn., Sept. 14, 2026 (GLOBE NEWSWIRE) — Grayscale Investments®, the world’s largest digital asset-focused investment platform*, today announced the launch of Grayscale Model Portfolios, a new suite of professionally constructed model portfolios that provide suggested allocations across the digital asset ecosystem, with each model designed around a distinct investment objective. The launch expands Grayscale’s advisor-focused offering with a portfolio-based approach to digital asset investing.

“Advisors are increasingly looking for ways to bring digital assets into client portfolios without having to build and maintain allocations asset by asset,” said Laurie Katz, Global Head of Distribution at Grayscale. “Grayscale Model Portfolios are designed to meet that need, combining our portfolio construction expertise with more than a decade of digital asset experience so advisors can offer clients thoughtfully constructed digital asset exposure through a single, familiar framework.”

Each Grayscale Model Portfolio combines multiple digital asset exchange traded products within a single strategy, giving advisors a more efficient way to access the breadth of the asset class than constructing and managing individual positions. Asset selection, position sizing, diversification, and rebalancing are incorporated into each model’s methodology, helping advisors implement and maintain digital asset exposure within a consistent portfolio framework.

Grayscale Model Portfolios launch with four strategies, each designed around a distinct investment objective:

  • Digital Assets Core Plus: Build a foundational digital asset allocation. Core Plus is designed to provide broad exposure to established digital assets, combining Bitcoin (BTC) and Ethereum (ETH) with select leading assets such as Solana (SOL) and Chainlink (LINK). The portfolio is market-cap weighted, rebalanced quarterly, and subject to a 40% weighting cap per asset.
  • Digital Assets Leaders: Access the leaders of the digital asset market. Digital Assets Leaders is designed to provide exposure to the five largest eligible digital assets held in single-asset Grayscale ETPs. As market leadership evolves, the portfolio adjusts to maintain exposure to leading assets. The portfolio is market-cap weighted, rebalanced quarterly, and subject to a 40% weighting cap per asset.
  • Digital Assets Next Gen: Expand beyond core digital assets. Digital Assets Next Gen is a portfolio of crypto assets providing exposure to established and emerging digital assets, excluding Bitcoin, across the broader digital asset economy. The portfolio holds up to 10 eligible assets, is market-cap weighted, rebalanced quarterly, and subject to a 40% weighting cap per asset.
  • Digital Assets Infrastructure: Access the protocols powering digital asset innovation. Digital Assets Infrastructure provides exposure to digital assets underlying protocols supporting smart contracts, tokenization, and other foundational applications across the digital asset economy. The portfolio is market-cap weighted, rebalanced quarterly, and subject to a 40% weighting cap per asset.

Grayscale Advisors, LLC will deliver Grayscale Model Portfolios directly to financial platforms, which make the models available to advisors for implementation in client accounts. Advisors implementing the models retain full discretion over how allocations are applied to their clients’ accounts, allowing digital asset exposure to be managed alongside the rest of a client’s portfolio. For additional information about Grayscale Model Portfolios, please visit: https://www.grayscale.com/model-portfolios

About Grayscale
Grayscale is the world’s largest digital asset-focused investment platform with a mission to make digital asset investing simpler and open to all investors. Founded in 2013, Grayscale has been at the forefront of bringing digital assets into the mainstream. The firm has a long history of firsts, including launching the first Bitcoin and Ethereum exchange traded products in the United States. Grayscale continues to pioneer the asset class by providing investors, advisors, and institutional allocators with access to a broad range of digital assets through a comprehensive suite of investment products spanning ETFs, private funds, and diversified strategies. For more information, please follow @Grayscale or visit grayscale.com.

Media Contact
press@grayscale.com

Client Contact
866-775-0313
info@grayscale.com

*Largest digital asset-focused investment platform based on assets under management (“AUM”) as of 6/30/2026. For other companies in this category, AUM is considered as of most recent public disclosure.

This information should not be relied upon as research, investment advice, or a recommendation by Grayscale regarding (i) the funds, (ii) the use or suitability of the model portfolios or (iii) any security in particular. Only an investor and their financial professional know enough about their circumstances to make an investment decision.

Carefully consider the funds’ investment objectives, risk factors, and charges and expenses before investing. This and other information can be found in the funds’ prospectuses or, if available, the summary prospectuses, which may be obtained by visiting Grayscale.com. Read the prospectus carefully before investing.

Investing involves a high degree of risk and heightened volatility, including possible loss of principal. An investment is not suitable for all investors, may be deemed speculative and is not intended as a complete investment program. An investment should be considered only by persons who can bear the risk of total loss associated with an investment. An investment in any Grayscale product is not a direct investment in any cryptocurrency.

The strategies discussed are strictly for illustrative and educational purposes and are not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. There is no guarantee that any strategies discussed will be effective.

Grayscale Advisors, LLC (“Grayscale Advisors” or the “Firm”) also provides model portfolios to financial intermediaries (“Model Recipients”), which determine whether the models are appropriate for their clients and implement them at their own discretion. Grayscale Advisors does not exercise investment discretion over Model Recipient client accounts, charge Model Recipients or their clients a direct advisory fee, have a direct advisory relationship with those clients, or owe them a fiduciary duty. Model Recipients are responsible for suitability and best-interest determinations, implementation, trade execution and client reporting. The models are not tailored to individual Model Recipients or their clients.

Grayscale Advisors, a registered investment adviser, manages Model Portfolio Strategies that invest in digital asset exchange-traded products (“ETPs”), including ETPs sponsored by its affiliate, Grayscale Investments Sponsors, LLC (“GSIS”). Initial capital for the Model Portfolio Strategies was provided by Grayscale Operating, LLC (“GSO”), the Firm’s parent company. Foreside Fund Services, LLC is the marketing agent for Grayscale ETPs. In connection with the Grayscale ETPs, which may be included in the Model Portfolio Strategies, GSIS, an affiliate, receives Sponsor’s Fees and certain fees related to staking.
Foreside Fund Services, LLC is the distributor and Grayscale Advisors, LLC (“GSA”) is the adviser of Grayscale ETFs. Foreside is not related to GSA or its affiliates.

© 2026 Grayscale. All trademarks, service marks and/or trade names (e.g., G™, GRAYSCALE®, GRAYSCALE CRYPTO SECTORS™, and GRAYSCALE INVESTMENTS®) are owned and/or registered by Grayscale.

Forum Expands Ecosystem Readiness Alongside Groundbreaking Pre-Standard ISAC and Live Sports Companion Milestones

NEW YORK, Sept. 14, 2026 (GLOBE NEWSWIRE) — Verizon today announced a major acceleration in the development of next-generation wireless architectures with the formal expansion of the Verizon 6G Innovation Forum (6GIF). Nine industry heavyweights—Amazon Web Services (AWS), Cisco, Intel, Keysight Technologies, MediaTek, NVIDIA, Palo Alto Networks, Rohde & Schwarz and VIAVI Solutions—have officially joined the forum, launched last year to establish an open, diversified, and resilient 6G ecosystem and develop foundational 6G technologies.

“By expanding our Innovation Forum and refining live edge-AI trials today, we are ensuring the AI-native 6G network is built from day one to scale 5G Advanced capabilities and translate these next-generation technologies into meaningful, real-world experiences for our customers,” said Yago Tenorio, Chief Technology Officer and Senior Vice President of Technology Development at Verizon. “With 6G, our collaborative objective is fundamentally bottom-up and use-case-driven. We are designing the next generation of connectivity with a specific target already in mind: enabling and scaling AI workloads and the massive AI ecosystem—particularly the emerging class of AI-enabled wearables like untethered smart glasses, as well as pioneering Integrated Sensing and Communication (ISAC) technologies.”

The Verizon 6G Innovation Forum which includes founding members Ericsson, Samsung, Nokia, Meta, and Qualcomm Technologies focuses on unlocking the full potential of 6G by trialing new use cases, testing new spectrum bands and bandwidth, and ensuring global alignment with global standards bodies like the 3GPP. The arrival of the nine new members injects critical multi-disciplinary capabilities across cloud services, advanced silicon and accelerated computing, independent automated test emulation, network security and immersive device graphics simulation.

Pioneering Real-World ISAC Trials with Founding Partners
To move 6G from theoretical discussion into practical reality, Verizon highlighted recent successful field trials with founding members Samsung and Qualcomm targeting Integrated Sensing and Communication (ISAC) use cases. ISAC essentially transforms the cellular network into a massive, distributed radar-like sensor without the need for physical cameras. Using 5G Advanced capabilities, the companies explored how ISAC could support public safety, environmental awareness and event management, creating a path to evolve these capabilities with 6G.

  • Crowd Density Detection Demo with Samsung: Staged live at a major international soccer celebration in Dallas, Texas, this milestone represented the industry’s first AI-powered ISAC trial on a virtualized Radio Access Network (vRAN) for crowd detection. Using a single 5G base station and 40MHz of CBRS spectrum, the network tracked the raw radio variations from six localized Samsung Galaxy smartphones. Samsung’s AI RAN and edge AI platform, Network in a Server (NIS) then analyzed these ambient wireless signal changes to generate real-time crowd-density heatmaps on commercial phones and a tablet. The trial validated how network-native sensing can enable real-time intelligence for large-scale events, which could allow event organizers to monitor spectator flows in real-time, streamline gate operations, reduce concession line wait times, and proactively address overcrowding risks.1
  • Drone and Vehicle Safety Tracking Demo with Qualcomm: Conducted at Qualcomm’s San Diego campus, this trial demonstrated the network’s ability to seamlessly multitask. Utilizing 100 to 400MHz of millimeter-wave spectrum and four synchronized Transmission and Reception Points (TRPs), the system successfully mapped and tracked the position and velocity of an airborne target and moving ground vehicles. Crucially, the network maintained radar-like tracking of the drone while simultaneously providing uninterrupted, high-speed 5G Standalone (SA) mobile communications to a phone user on the ground. This highlights 6G’s potential to provide the foundational, secure tracking infrastructure required for future autonomous drone safety.

Trialing an AI Sports Companion Application
Further driving its strategy of building infrastructure around the applications of tomorrow, Verizon showcased a prototype of an AI Sports Companion application. Next-generation, AI-native devices and wearables like smart glasses will demand ultra-low latency and a more balanced uplink-downlink model as the glasses will generate as much uplink data as downloading content.

Powered directly by the Verizon Edge Network, this research prototype application showed how that architectural shift could translate into a premium fan experience. Wearing Meta AI glasses, users could enjoy a game in a stadium or at home completely hands-free without looking down at a phone. Utilizing an ultra-fast edge network with a locally optimized Small Language Model (SLM), a NVIDIA DGX Spark and statistics from SportsDataIO, the application allowed users to verbally ask for real-time player statistics, live score interpretations, or game-winning probabilities, receiving instant, spoken answers right in their ear. The prototype was designed to explore how future technology could eliminate the friction of juggling multiple apps and keep fans immersed in the game while providing deep, real-time insights.

The Path to 6G Deployment
Looking forward, Verizon 6GIF members will continue to share learnings from future ecosystem demonstrations involving ISAC, digital twins, robotics, AI and advanced wearables. Verizon views the 2028 Summer Olympics in Los Angeles as the ultimate interim proving ground on the road to commercial 6G deployment.

With Verizon’s dedicated 6G Lab already established directly in Los Angeles, the host city will serve as a live, real-world stage to stress-test the massive capacity demands and early use cases of the AI-native era, delivering practical user experiences that prove and validate the next generation of wireless technology.

This announcement was originally published by Verizon. Read the original press release.

Media contact:
Chris Ashraf
Christina.moon.ashraf@verizon.com
201-320-4259

1The crowd sensing demo measures crowd density which is the number of people in a given area, at any given time. Individual users or objects are not identified. No information is obtained about the identity of the individuals.

Verizon Communications Inc. (NYSE, Nasdaq: VZ) powers and empowers how its millions of customers live, work and play, delivering on their demand for mobility, reliable network connectivity and security. Headquartered in New York City, serving countries worldwide and nearly all of the Fortune 500, Verizon generated revenues of $138.2 billion in 2025. Verizon’s world-class team never stops innovating to meet customers where they are today and equip them for the needs of tomorrow. For more, visit verizon.com or find a retail location at verizon.com/stores

VERIZON’S ONLINE MEDIA CENTER: News releases, stories, media contacts and other resources are available at verizon.com/news. News releases are also available through an RSS feed. To subscribe, visit www.verizon.com/about/rss-feeds/.

Commissioning of Carbon Dioxide Degassing System Ahead of Schedule Marks Key Milestone in Capacity Enhancement Program

ENGLEWOOD, Colo., Sept. 14, 2026 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ: GEVO) today announced continued progress on the debottlenecking initiative at its Gevo North Dakota (“GND”) facility in Richardton, North Dakota, including the successful commissioning of a new beer degassing system ahead of schedule which will capture and sequester more CO₂. The debottlenecking will result in a 10-15 percent increase in GND output and returns and closely follows the successful commissioning of a steam turbine project in August.

The debottlenecking program is designed to enhance operating efficiency and increase production capacity at GND as the facility advances toward its targeted production capacity of approximately 75 million gallons per year. The project includes three primary upgrades:

  • Addition of a third liquefaction tank to expand capacity and improve the yield of corn starch to sugars
  • Addition of a fifth fermenter to increase fermentation residence time to enable the production of more ethanol and CO₂
  • Installation of a beer degassing system to capture and sequester additional CO₂ from the ethanol process

The CO₂ beer degassing system is currently being commissioned, several weeks earlier than originally planned. This equipment will enable GND to increase CO₂ recovery, unlock distillation capacity, and lower the facility CI score.

“This milestone represents another step forward in our efforts to optimize GND and unlock additional value from an already strong operating asset,” said Gevo Chief Executive Officer Paul Bloom. “Our debottlenecking program is focused on practical, high-return improvements that enhance production efficiency, carbon capture performance and overall facility economics.”

Construction and installation activities associated with liquefaction and fermentation continue to progress on schedule and both assets are expected to be operational by the end of 2026.

GND also recently completed the commissioning of a steam turbine project. The project lowers the plant energy consumption by optimizing the steam usage inside the plant while lowering the amount of purchased electricity. This project was already started prior to Gevo’s acquisition of the facility and was successfully integrated into plant operations in August.

The steam turbine and debottlenecking project are both examples of Gevo’s ability to unlock process capacity while operating safely and efficiently. These projects are laying the groundwork for the planned 75Mgpy expansion of GND which is anticipated to approximately double the output and returns from GND and is expected to be completed in 2028.

About Gevo

Gevo is a next-generation diversified energy company committed to fueling America’s future with cost-effective, drop-in fuels that contribute to energy security, abate carbon, and strengthen rural communities to drive economic growth. Gevo’s innovative technology can be used to make a variety of renewable products, including sustainable aviation fuel (SAF), motor fuels, chemicals, and other materials that provide U.S.-made solutions. Gevo’s business model includes developing, financing, and operating production facilities that create jobs and revitalize communities. Gevo owns and operates an ethanol plant with an adjacent carbon capture and storage (CCS) facility and Class VI carbon-storage well. Gevo also owns and operates one of the largest dairy-based renewable natural gas (RNG) facilities in the United States, turning by-products into clean, reliable energy. Additionally, Gevo developed the world’s first production facility for specialty alcohol-to-jet (ATJ) fuels and chemicals operating since 2012. Gevo is currently developing the world’s first large-scale ATJ facility to be co-located at our North Dakota site. Gevo’s market-driven “pay-for-performance” approach regarding carbon and other sustainability attributes helps deliver value to our local economies. Through its Verity subsidiary, Gevo provides transparency, accountability, and efficiency in tracking, measuring, and verifying various attributes throughout the supply chain. By strengthening rural economies, Gevo is working to secure a self-sufficient future and to make sure value is brought to the market.

For more information, please visit www.gevo.com.

Forward-Looking Statements

Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to a variety of matters, without limitation, including the expected future production capacity at GND, expected operational efficiencies of the debottlenecking project, the ability to capture and sequester additional carbon following the debottlenecking and other statements that are not purely statements of historical fact. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Gevo and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Gevo undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Gevo believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Gevo in general, see the risk disclosures in the Annual Report on Form 10-K of Gevo for the year ended December 31, 2025, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the U.S. Securities and Exchange Commission by Gevo.

Media Contact
Communications@gevo.com

IR Contact
IR@Gevo.com

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.